Melioidosis, an infection caused by the Gram-negative bacterium Burkholderia pseudomallei, has earned the nickname ‘the great mimicker’ owing to its tendency to resemble common infections, often leading to a delayed diagnosis and high mortality. We report three cases where it mimicked scrub typhus, tubercular arthritis, and Klebsiella pneumoniae infection. The diagnosis of melioidosis was achieved by extensive workup; our case series sends the lesson that none should stop and settle for less, but continuously search for the actual pathogen where no adequate response to treatment is perceived.
WhitmoreA. An account of a glanders-like disease occurring in Rangoon. J Hyg (Lond)1913; 13: 1–34.
2.
WhitmoreAKrishnaswamiCS. An account of the discovery of a hitherto undescribed infective disease occurring among the population of Rangoon. Indian Med Gazette1912; 47: 262–267.
3.
LimmathurotsakulDGoldingNDanceDAB, et al.Predicted global distribution of Burkholderia pseudomallei and burden of melioidosis. Nat Microbiol2016; 1: 15008.
4.
CurrieBJ. Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment. Semin Respir Crit Care Med2015; 36: 111–125.
5.
WiersingaWJVirkHSTorresAG, et al.Melioidosis. N Engl J Med2012; 367: 1035–1044.
6.
DanceDA. Melioidosis as an emerging global problem. Acta Trop2000; 74: 115–119.
MukhopadhyayCShawT. Burden of melioidosis in India and South Asia: challenges and ways forward. Lancet Reg Health Southeast Asia2022; 3: 100034.
9.
ChaowagulWWhiteNJDanceDA, et al.Melioidosis: a major cause of community-acquired septicemia in northeastern Thailand. J Infect Dis1989; 159: 890–899.
10.
CurrieBJJacupsSP. Intensity of rainfall and severity of melioidosis, Australia. Emerg Infect Dis2003; 9: 1538–1542.
11.
CurrieBJFisherDAHowardDM, et al.Endemic melioidosis in tropical northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis2000; 31: 981–986.
12.
CurrieBJJacupsSPChengAC, et al.Melioidosis epidemiology and risk factors from a prospective whole-population study in northern Australia. Trop Med Int Health2004; 9: 1167–1174.
13.
CurrieBJWardLChengAC. The epidemiology and clinical spectrum of melioidosis: 540 cases from the 20 year Darwin prospective study. PLoS Negl Trop Dis2010; 4: e900.
14.
BarmanPSidhwaHShirkhandePA. Melioidosis: a case report. J Glob Infect Dis2011; 3: 183–186.
15.
WongyikulPKlangbudWKChatatikunM, et al.Co-infections and their prognostic impact on melioidosis mortality: a systematic review and individual patient data meta-analysis. Epidemiologia2025; 6: 17.
16.
WhiteNJDanceDAChaowagulW, et al.Halving of mortality of severe melioidosis by ceftazidime. Lancet1989; 2: 697–701.
17.
ChengACFisherDAAnsteyNM, et al.Outcomes of patients with melioidosis treated with meropenem. Antimicrob Agents Chemother2004; 48: 1763–1765.
18.
SimpsonAJOpalSMAngusBJ, et al.Differential antibiotic-induced endotoxin release in severe melioidosis. J Infect Dis2000; 181: 1014–1019.
19.
WalshALSmithMDWuthiekanunV, et al.Postantibiotic effects and Burkholderia (Pseudomonas) pseudomallei: an evaluation of current treatment. Antimicrob Agents Chemother1995; 39: 2356–2358.
